Skip to main content
. 2021 Oct 5;23:239–253. doi: 10.1016/j.omto.2021.09.008

Figure 4.

Figure 4

Strategic design to improve safety and efficacy

(A) Trends in choice of viral vector and delivery site according to tumor type. Each line represents a single study (trial or article). (B) Maximum tolerated dose per virus type in patients. (C) Frequency of injections applied.